Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $171.88 | 1 | 64.2% |
| Food and Beverage | $95.94 | 1 | 35.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $171.88 | 1 | $0 (2020) |
| Acorda Therapeutics, Inc | $95.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $171.88 | 1 | Biogen, Inc. ($171.88) |
| 2019 | $95.94 | 1 | Acorda Therapeutics, Inc ($95.94) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/20/2020 | Biogen, Inc. | — | — | Cash or cash equivalent | $171.88 | Research |
| Study: Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | ||||||
| 06/04/2019 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | Cash or cash equivalent | $95.94 | General |
| Category: PARKINSONS DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction | Biogen, Inc. | $171.88 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 157 | 175 | $54,410 | $18,289 |
| 2022 | 7 | 176 | 208 | $70,080 | $21,453 |
| 2021 | 5 | 131 | 135 | $52,305 | $16,465 |
| 2020 | 2 | 46 | 50 | $18,098 | $5,814 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 27 | 27 | $12,195 | $3,417 | 28.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 19 | 22 | $7,480 | $2,664 | 35.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 20 | $8,075 | $2,653 | 32.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 23 | $7,210 | $2,532 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $6,715 | $2,108 | 31.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $4,730 | $1,685 | 35.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 14 | 14 | $3,520 | $1,361 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $2,715 | $1,070 | 39.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 19 | $1,770 | $798.00 | 45.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 59 | $23,195 | $7,907 | 34.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $13,225 | $3,105 | 23.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 26 | 28 | $8,300 | $2,505 | 30.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $7,830 | $2,460 | 31.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 38 | $7,550 | $2,305 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 22 | $6,105 | $1,914 | 31.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $3,875 | $1,256 | 32.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 35 | $20,125 | $5,908 | 29.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 29 | 33 | $10,395 | $3,680 | 35.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 23 | 23 | $7,015 | $2,072 | 29.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 14 | 14 | $5,410 | $2,061 | 38.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 17 | $6,630 | $1,949 | 29.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 13 | 13 | $2,730 | $795.21 | 29.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 37 | $11,026 | $3,553 | 32.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $7,072 | $2,262 | 32.0% |
About Dr. Yan Hou, MD
Dr. Yan Hou, MD is a Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2015. The National Provider Identifier (NPI) number assigned to this provider is 1477930451.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yan Hou, MD has received a total of $267.82 in payments from pharmaceutical and medical device companies, with $171.88 received in 2020. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "" ($171.88).
As a Medicare-enrolled provider, Hou has provided services to 510 Medicare beneficiaries, totaling 568 services with total Medicare billing of $62,021. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Student in an Organized Health Care Education/Training Program, Vascular Neurology
- Location Hartford, CT
- Active Since 04/29/2015
- Last Updated 08/02/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1477930451
Products in Payments
- INBRIJA (Drug) $95.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hartford
Dr. Tapan Mehta, M.b.b.s, M.B.B.S
Neurology — Payments: $31,259
Dr. Lawrence Bluth, M.d, M.D
Neurology — Payments: $14,628
Dr. Stephen Conway, M.d, M.D
Neurology — Payments: $11,972
Dr. Brian Wong, M.d, M.D
Neurology — Payments: $8,026
Keshav Rao, Md, MD
Neurology — Payments: $3,525
Alexis Demopoulos, Md, MD
Neurology — Payments: $3,008